BRGX supply chain intelligence for BioRegenx, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.
Data compiled by Redley Lamar · ChainSifter Intelligence
BioRegenx, Inc. (BRGX) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| GLYCOCHECK-B-V | GLYCOCHECK-B-V | 92% | The Company has a worldwide distribution agreement with GlycoCheck B.V. for the GlycoCheck machine distribution. |
| NULIFE-SCIENCES-INC | NULIFE-SCIENCES-INC | 85% | FINANCIAL STATEMENTS FOR THE YEARS ENDED DECEMBER 31, 2025 AND 2024 NOTE 1— SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Organization and Business The Company, BioRegenx, Inc., develops and manufacture… |
| SKYE | Skye Bioscience, Inc. | 72% | health utilizing the latest in technologies and top of class products in the health and wellness sector. He has served in that role since October 2012 to present. From March 2016 to present, Mr. Resi… |
| SKYE | Skye Bioscience, Inc. | 72% | Reciprocal relationship from SKYE graph: Reciprocal relationship from BRGX graph: Reciprocal relationship from SKYE graph: Reciprocal relationship from BRGX graph: health utilizing the latest in tech… |
| DOCSUN-BIOMEDICAL-HOLDINGS-INC | DOCSUN-BIOMEDICAL-HOLDINGS-INC | 62% | NOTE 2— INVENTORIES Inventories, which consist of finished goods, are comprised of the following: Schedule of inventories Finished Goods: 12/31/2025 12/31/2024 Medical testing $ 4,849 $ 23,476 Wellne… |
| FINDIT-AI-CONNECT-INC | FINDIT-AI-CONNECT-INC | 62% | . NuLife Sciences, a MVHS sister company, offers a range of supplements under the MyBodyRx ® brand. 3 Wholly Owned Subsidiary MyBodyRx, LLC (MyBodyRx) is a sales and product development company that … |
| INC-NULIFE-SCIENCES-INC | INC-NULIFE-SCIENCES-INC | 62% | . NuLife Sciences, a MVHS sister company, offers a range of supplements under the MyBodyRx ® brand. 3 Wholly Owned Subsidiary MyBodyRx, LLC (MyBodyRx) is a sales and product development company that … |
| MERGER-BIOREGENX-INC | MERGER-BIOREGENX-INC | 62% | FINANCIAL STATEMENTS FOR THE YEARS ENDED DECEMBER 31, 2025 AND 2024 NOTE 1— SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Organization and Business The Company, BioRegenx, Inc., develops and manufacture… |
| OTC-MARKETS-GROUP | OTC-MARKETS-GROUP | 62% | der-by-order basis for the entire order. In the event an order has not been fulfilled or partially filled revenues are not recognized for the portion of the order for which the performance obligation… |
| WHOLLY-OWNED-SUBSIDIARY-MYBODYRX-LLC | WHOLLY-OWNED-SUBSIDIARY-MYBODYRX-LLC | 62% | . NuLife Sciences, a MVHS sister company, offers a range of supplements under the MyBodyRx ® brand. 3 Wholly Owned Subsidiary MyBodyRx, LLC (MyBodyRx) is a sales and product development company that … |
| Instrument | Description | Confidence | Evidence |
|---|---|---|---|
| BRGX-DEBT-8355 | Xbrl Convertible | 90% | xbrl convertible detail from xbrl 2021-03-31. |
| BRGX-DEBT | Debt stack $1.2M | 90% | Market cache reports total debt of $1.2M. |
| BRGX-DEBT-8354 | Warrants outstanding: 2238482 | 90% | xbrl warrant detail from xbrl 2024-03-31. |